Hyam Levitsky's Net Worth
$1.33 Million
Who is Hyam Levitsky?
Hyam Levitsky has an estimated net worth of $1.33 Million. This is based on reported shares across multiple companies, which include Century Therapeutics, Inc., ANTIGENICS INC /DE/, Replimune Group, Inc., and Juno Therapeutics, Inc..
SEC CIK
Hyam Levitsky's CIK is 0001375792
Past Insider Trading and Trends
2008 was Hyam Levitsky's most active year for acquiring shares with 4 total transactions. Hyam Levitsky's most active month to acquire stocks was the month of March. 2016 was Hyam Levitsky's most active year for disposing of shares, totalling 3 transactions. Hyam Levitsky's most active month to dispose stocks was the month of May. 2007 saw Hyam Levitsky paying a total of $45,300.00 for 15,000 shares, this is the most they've acquired in one year. In 2016 Hyam Levitsky cashed out on 28,872 shares for a total of $1,222,807.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Century Therapeutics, Inc. (IPSC) Snapshot price: $1.44
President R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 24K |
—
|
—
| 24K |
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ANTIGENICS INC /DE/ (AGEN) Snapshot price: $4.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
∞
| 15.38K |
—
|
—
| 15.38K |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Replimune Group, Inc. (REPL) Snapshot price: $10.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Juno Therapeutics, Inc. No price found
EVP, Research & CSO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.54% | 14.63K |
—
|
—
| 131.33K |
Feb 7
| |||
Form 4
| -9.62% | -12.42K |
$42.77 | -$531,080.84 | 116.7K |
Scheduled
|
Jun 17
| ||
Form 4
| -11.30% | -16.45K |
$42.04 | -$691,726.16 | 129.12K |
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
∞
| 145K |
—
|
—
| 145K |
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |